GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’
BioPharma Dive
The findings supporting bepirovirsen were deemed a historic moment by physicians and validate a drug that has clear blockbuster potential, according to one analyst.
pharminent
May 28, 2026 (Last updated: May 29, 2026)
BioPharma Dive
The findings supporting bepirovirsen were deemed a historic moment by physicians and validate a drug that has clear blockbuster potential, according to one analyst.
